Wesley Research Institute
Donate
Now

Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

 

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute

Phase

3

Study type

Industry Sponsored
Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

Lead investigator

  • Dr Daman Langguth

Clinical trial coordinator

  • Venita Bali

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

 

Latest News

Coeliac Disease Myths vs Facts

In this article, we separate myth from fact and explore more about coeliac disease, including who should be tested, why first-degree relatives are at greater risk, what a gluten-free diet really involves, and why symptoms don't always fit the textbook description.

Spotlight on Clinical Trial Coordinator Chris: Making Every Patient Experience Count

Behind every clinical trial is a team dedicated to improving patient outcomes, and Chris is one of the people at the heart of that mission.

Why Do We Need Treatments Beyond the Gluten-Free Diet for Coeliac Disease? 

While a gluten-free diet (GFD) is the cornerstone of coeliac disease management, it is not a perfect solution. This blog explores the limitations of the gluten-free diet and why additional treatments are necessary to improve long-term health outcomes for people with coeliac disease.
1 2 3 39
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram